Alliance Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Barels who wrote (222)	3/26/1998 5:41:00 PM
From: John R Resseger	Read Replies (3) of 548

Bob 1 There has never been any problems with any impurities with Liquivent 2.Boeringer- Inglehiem ceased doing business with ALLP because A. The Advocate for Oxygent at B-I died. B. J&J wanted an exclusive deal for Oxygent 3. Btw the joint venture with J&J has never been better. J&J has speeded up milestone payments. 4. Any problem with Liqivent and Hyper inflation of lungs, is species specific to rabbits. 5. Horchest left because of internal problems in the fatherland. They still own 1M shares of ALLP. They also left behind several million dollars. ALLP issued a press release in January, stating they were not seeking a partner for Liqivent. They will see it through the trials and then seek a marketing partner. They have more than enough cash to do so. 6. If SYBD has a superior fluerocarbon they would have received funding a long time ago, or ALLP would have bought it. ALLP has $70M in cash. 7. Yes I do hype this stock. It deserves attention. 8. The recklessness of your portrayal of ALLP is not consistent with the carefulness required of a chemist. 9.. The touch of sarcasm was appropriate considering the crude attempt to slam a good stock. 10. Good Morgan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next